Benjamin Whalley,Claire Williams,Gary Stephens,Takashi Futamura
申请号：
GB201100042
公开号：
GB2487183B
申请日:
2011.01.04
申请国别(地区):
GB
年份:
2018
代理人:
摘要：
The phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy, in particular epilepsy characterised by generalised seizures or temporal lobe seizures where the CBDV may be used in an isolated form or as a botanical drug substance. Preferably, CBDV is used with one or more therapeutically effective phytocannabinoids such as tetrahydrocannabivarin (THCV) and cannabidiol (CBD), and in combination with a standard anti-epileptic drug selected from ethosuximide, valproate or phenobarbital. A cannabis plant extract for use in the treatment of epilepsy, wherein the extract comprises at least 50 wt% of a phytocannabinoid fraction including CBDV as principal phytocannabinoid and CBD as secondary phytocannabinoid, and a non-phytocannabinoid fraction including monoterpenes and sesquiterpenes is also outlined.
